High density, strong growth

Ceresana analyzes the global HDPE market.

Halogen-free flame retardants

ClariantExolit? flame retardants receive EU recognition.

China issues final anti-dumping duties on European chemical

Commerce Ministry sets duties between 6.6 and 37.7 percent on European exports of toluene di-isocyanate, used in the production of polyurethane, plastics and rubber

Analysis: Solar trade war promises order bonanza for Taiwan

If the EU also introduces punitive tariffs on Chinese-made solar equipment, Taiwanese companies may inch back toward profitability

Japan recommends cutting solar tariff as equipment prices fall

Officials say incentives can be cut without squeezing development plans amid a push to diversify sources of energy after the nuclear meltdown in Fukushima

Big Pharma battle threatens to delay Pacific trade pact

Activists pushing for greater public access to cheap generics are sparring with the pharmaceuticals industry amid ongoing Trans-Pacific Partnership (TPP) talks

Ashland introduces Lipigenine? Biofunctional

Ashland will introduce one of its latest innovative products Lipigenine biofunctional, which can support skin care cosmetic manufacturers to develop the formulations to fit and satisfy the consumers of all ages.

KOPLAS 2013 opens today; expects over 70,000 visitors

The opening ceremony for KOPLAS 2013 was held today, marking the start of the 22nd edition of this major show that has played significant role in Korea's plastics and rubber industry.

IFF facility in Guangzhou now in testing stage

One of the largest manufacturing sites for flavours and fragrances in Asia will begin production in Q3

Anti-MS drug may lead to fatal brain infection

Early detection of multiple sclerosis (MS) treatment complication from the drug natalizumab may improve survival

Positive clinical results for MR reduction device

Abbott's minimally invasive MitraClip System for mitral regurgitation (MR) demonstrates positive clinical and quality-of-life results for patients too high risk for surgery

Stent demonstrates low event rates through three years

Separate three-year study demonstrates PROMUS Element Stent has significantly less vessel straightening than the Xience V Stent